139 related articles for article (PubMed ID: 34911380)
41. Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D
Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247
[TBL] [Abstract][Full Text] [Related]
42. Totally implantable venous access devices via subclavian vein: a retrospective study of 368 oncology patients.
Ozyuvaci E; Kutlu F
Adv Ther; 2006; 23(4):574-81. PubMed ID: 17050500
[TBL] [Abstract][Full Text] [Related]
43. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
44. Tip position of long-term central venous access devices used for parenteral nutrition.
DeChicco R; Seidner DL; Brun C; Steiger E; Stafford J; Lopez R
JPEN J Parenter Enteral Nutr; 2007; 31(5):382-7. PubMed ID: 17712146
[TBL] [Abstract][Full Text] [Related]
45. [Long-term outcomes and complications of upper arm central venous access ports].
Ide Y; Mikami K; Murata K
Gan To Kagaku Ryoho; 2013 Mar; 40(3):331-5. PubMed ID: 23507594
[TBL] [Abstract][Full Text] [Related]
46. Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.
Berardi R; Rinaldi S; Santini D; Vincenzi B; Giampieri R; Maccaroni E; Marcucci F; Francoletti M; Onofri A; Lucarelli A; Pierantoni C; Tonini G; Cascinu S
Support Care Cancer; 2015 May; 23(5):1295-302. PubMed ID: 25326782
[TBL] [Abstract][Full Text] [Related]
47. Experience at a single institution with endovascular treatment of mechanical complications caused by implanted central venous access devices in pediatric and adult patients.
Bessoud B; de Baere T; Kuoch V; Desruennes E; Cosset MF; Lassau N; Roche A
AJR Am J Roentgenol; 2003 Feb; 180(2):527-32. PubMed ID: 12540466
[TBL] [Abstract][Full Text] [Related]
48. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
49. The "Arm-to-Chest Tunneling" technique: A modified technique for arm placement of implantable ports or central catheters.
Kehagias E; Tsetis D
J Vasc Access; 2019 Nov; 20(6):771-777. PubMed ID: 30939969
[TBL] [Abstract][Full Text] [Related]
50. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies.
Patel GS; Jain K; Kumar R; Strickland AH; Pellegrini L; Slavotinek J; Eaton M; McLeay W; Price T; Ly M; Ullah S; Koczwara B; Kichenadasse G; Karapetis CS
Support Care Cancer; 2014 Jan; 22(1):121-8. PubMed ID: 24005884
[TBL] [Abstract][Full Text] [Related]
51. Symptomatic catheter-associated thrombosis in pediatric trauma patients: Choose your access wisely.
McLaughlin CM; Barin EN; Fenlon M; Azen C; Deakers TW; Stein JE; Bliss DW; Upperman JS; Jensen AR
Surgery; 2019 Dec; 166(6):1117-1121. PubMed ID: 31526580
[TBL] [Abstract][Full Text] [Related]
52. Association between delivery methods for red blood cell transfusion and the risk of venous thromboembolism: a longitudinal study.
Rogers MAM; Blumberg N; Bernstein SJ; Flanders SA; Chopra V
Lancet Haematol; 2016 Dec; 3(12):e563-e571. PubMed ID: 27818170
[TBL] [Abstract][Full Text] [Related]
53. Complications of indwelling venous access devices in cancer patients.
Eastridge BJ; Lefor AT
J Clin Oncol; 1995 Jan; 13(1):233-8. PubMed ID: 7799025
[TBL] [Abstract][Full Text] [Related]
54. A comparison of infections and complications in central venous catheters in adults with solid tumours.
Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
[TBL] [Abstract][Full Text] [Related]
55. Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP).
Decousus H; Bourmaud A; Fournel P; Bertoletti L; Labruyère C; Presles E; Merah A; Laporte S; Stefani L; Piano FD; Jacquin JP; Meyer G; Chauvin F;
Blood; 2018 Aug; 132(7):707-716. PubMed ID: 29980524
[TBL] [Abstract][Full Text] [Related]
56. Comparative Complication Rates of 854 Central Venous Access Devices for Home Parenteral Nutrition in Cancer Patients: A Prospective Study of Over 169,000 Catheter-Days.
Cotogni P; Mussa B; Degiorgis C; De Francesco A; Pittiruti M
JPEN J Parenter Enteral Nutr; 2021 May; 45(4):768-776. PubMed ID: 32511768
[TBL] [Abstract][Full Text] [Related]
57. Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy.
Hamilton HC; Foxcroft DR
Cochrane Database Syst Rev; 2007 Jul; (3):CD004084. PubMed ID: 17636746
[TBL] [Abstract][Full Text] [Related]
58. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
Burbridge B; Goyal K
J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
[TBL] [Abstract][Full Text] [Related]
59. Totally implantable venous access devices - 20 years' experience of implantation in cystic fibrosis patients.
Royle TJ; Davies RE; Gannon MX
Ann R Coll Surg Engl; 2008 Nov; 90(8):679-84. PubMed ID: 18990281
[TBL] [Abstract][Full Text] [Related]
60. Radiologic placement of subcutaneous infusion chest ports for long-term central venous access.
Funaki B; Szymski GX; Hackworth CA; Rosenblum JD; Burke R; Chang T; Leef JA
AJR Am J Roentgenol; 1997 Nov; 169(5):1431-4. PubMed ID: 9353475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
